HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perioperative prophylaxis with single-dose cefazolin for liver transplantation: a retrospective study.

AbstractBACKGROUND:
Early infections are common during the first month after liver transplantation (LT), whereas no consensus exists on the optimal prophylactic antimicrobial therapy. We aimed to evaluate the effectiveness of cefazolin perioperative prophylaxis in LT.
PATIENTS AND METHODS:
We documented our experience with single-dose cefazolin as prophylaxis for LT. Infections occurring within 30 days following LT during 2006-2015 were documented retrospectively. Univariate and multivariate analyses of risk factors for infection were carried out.
RESULTS:
Among 113 LT recipients receiving cefazolin as prophylaxis, infections occurred in 50 (44%) patients, including surgical site infections (n=24, 21%) and bacteremia (n=14, 12%). Bacteria resistant to cefazolin were documented in 59/72 (82%) isolates. Enterococcal infections were documented in 6% (7/113). Almost half of the infections (44%) occurred in the first week following LT and the vast majority within 2 weeks. The 30-day mortality rate (7%, 8/113) was significantly higher among infected patients (7/50, 14% vs. 1/63, 1.6%, P=0.011). Model for End-stage Liver Disease score, age, and requirement for at least 5 U of packed red cells during transplantation were predictive for postoperative infections.
CONCLUSION:
In our center, cefazolin was insufficient as perioperative prophylaxis in LT. We suggest that all LT recipients should receive antibiotic prophylaxis targeting microorganisms on the basis of local bacterial ecology and patterns of resistance irrespective of preoperative or intraoperative risk assessment.
AuthorsLiran Statlender, Dafna Yahav, Haim Ben-Zvi, Ili Margalit, Ayelet Ferder, Elad Goldberg, Eytan Mor, Jihad Bishara, Jonathan Cohen
JournalEuropean journal of gastroenterology & hepatology (Eur J Gastroenterol Hepatol) Vol. 31 Issue 9 Pg. 1135-1140 (Sep 2019) ISSN: 1473-5687 [Electronic] England
PMID30896551 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Anti-Bacterial Agents
  • Cefazolin
Topics
  • Adult
  • Anti-Bacterial Agents (administration & dosage)
  • Antibiotic Prophylaxis
  • Bacteremia (epidemiology, microbiology, prevention & control)
  • Cefazolin (administration & dosage)
  • Female
  • Humans
  • Liver Failure (etiology, pathology, surgery)
  • Liver Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Surgical Wound Infection (epidemiology, microbiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: